Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ZGPAT |
| Upstream (Parents) |
|---|
| (<<) VTN → ZGPAT |
| (<<) NR1I3 → ZGPAT |
| (<<) NR1H4 → ZGPAT |
| (<<) CUX2 → ZGPAT |
| (<<) ESR1 → ZGPAT |
| (<<) AR → ZGPAT |
| (<<) MAFF → ZGPAT |
| Downstream (Children) |
|---|
| ZGPAT → MSX2 (>>) |
| ZGPAT → TFAP2C (>>) |
| ZGPAT → HNF4A (>>) |
| ZGPAT → SOX30 (>>) |
| ZGPAT → TEF (>>) |
| ZGPAT → TP63 (>>) |
| ZGPAT → HMG20B (>>) |
| ZGPAT → CSDA (>>) |
| ZGPAT → FOSL2 (>>) |
| ZGPAT → RORC (>>) |
| ZGPAT → MLXIPL (>>) |
| ZGPAT → NR1I2 (>>) |
| ZGPAT → NR2F1 (>>) |
| ZGPAT → PROX1 (>>) |
| ZGPAT → MSL3 (>>) |
| ZGPAT → FOXA2 (>>) |
| ZGPAT → RUNX3 (>>) |
